// App-Quantinova.ai

1258 : Autoimmune Hemolytic Anemia Confers Risk of Thromboembolism That Is Not Attributable to Usual Thrombosis Risk Factors: A Longitudinal, Retrospective Cohort Study Using the Stride Database

Researchers

Presenter

  • Evan C. Chen

Principal Investigators

  • Pooja D. Loftus

  • Susan C. Weber

  • Nhat Minh Hoang

  • James Gilbert

  • Shivaani Kummar

Medical Centers

  • Director of Informatics Systems and Software Development, Stanford University, Palo Alto, CA

  • Department of Medicine, Stanford University, Stanford, CA

  • Chief Medical Officer, True North Rx, Palo Alto, CA

  • Director, Phase I Clinical Research Program, Stanford University, Palo Alto, CA

  • Massachusetts General Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

Disease

  • Autoimmune hemolytic anemia

  • Venous thrombosis

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved